Ceren ACAR, Mustafa Mert SÖZEN, Şükrü KARTALCI

Presence of a genetic association between NRG-3 SNP rs17101193 and schizophrenia

Aim: NRG-3 gene is a member of neuregulin signaling pathway and alleles of several single nucleotide polymorphisms (SNP) locatedin this gene are suspected to be associated with schizophrenia. During this work, we have done a study to investigate the potentialassociation of the SNP rs17101193 of NRG-3 gene.Material and Methods: We used the DNA samples from 301 unrelated schizophrenia patients and 326 healthy control samplescollected from Malatya-Turkey to determine the SNP genotypes. After genotyping, we compared the genotypes and alleles in termsof distributions between cases and controls. We also applied the recessive models for both alleles to get a more clarified result. Weused Chi-Squared test and Fisher’s exact test for hypothesis testing.Results: Even though the difference between the case and control groups were not significant in context of distributions of twoalleles of rs17101193, the distributions of genotypes were significantly different (p = 0.046). On the other hand, one of the genotypes(AA) was seen only in the patients.Conclusion: The results of our analyses and statistical test indicated that rs17101193 SNP of NRG-3 gene has a potential to beassociated with schizophrenia and homozygosity of “A” allele seems to be a risk factor in our population. More evidence fromseparate case-control studies from different populations may be required to strengthen this idea.

PDF

___

1. Liddle P, Carpenter WT, Crow T. Syndromes of schizophrenia. Classic literature. Br J Psychiatry 1994;165:721-7.
2. Escudero I, Johnstone M. Genetics of schizophrenia. Curr Psychiatry Rep 2014;16:502-10.
3. Owen MJ, Craddock N, O’Donovan MC. Schizophrenia: genes at last? Trends Genet 2005;21;518-25.
4. Rodriguez-Murillo L, Gogos JA, Karayiorgou M. The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu Rev Med 2012; 63:63- 80.
5. Acar C, Sozen MM, Gozukara H, et al. Lack of association between catechol-Omethyltransferase and schizophrenia in a Turkish population. Turkish J Biochemistry 2015;40:205-9.
6. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002;71:877-92.
7. Stefansson H, Sarginson J, Kong A, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003;72:83-7.
8. Banerjee A, Macdonald ML, Borgmann-Winter KE, et al. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Res Bull 2010; 30:132-9.
9. Avramopoulos D. Neuregulin 3 and its roles in schizophrenia risk and presentation. Am. J. Med. Genet. B. Neuropsychiatr Genet 2018;177:257-66.
10. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006;15:132-40.
11. Hatzimanolis A, McGrath JA, Wang R. et al. Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients. Transl Psychiatry 2013;28:264-71.
12. First MB, Spitzer RL, Gibbon M, et al.Structured Clinical Interview for DSM-IV Axis I Disorders, Patient edition. New York: Biometrics Research Department, New York State Psychiatric Institute 1997.
13. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
14. Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;9:175-91.
15. Rico B, Marín O. Neuregulin signaling, cortical circuitry development and schizophrenia. Curr Opin Genet Dev 2011;21:262-70.